Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 455 results for "k mehrotra"

UP Lokayukta detects financial loss

Uttar Pradesh Lokayukt Justice(Retd) N K Mehrotra, probing large scale evasion of stamp duty on registration of lands in Mathura, today said he was extending the scope of inquiry to several big cities. The investigation would now cover more cities, ... NetIndia123.com, 1 week ago

2 images for "k mehrotra"

APN News, 3 months ago
India Today, 6 months ago
Indian Express

No action against RNN ex-MD, Lokayukta nudges Gov

In his report, Mehrotra had found Singh guilty under the Prevention of Corruption Act for awarding construction works worth Rs 858.95 crore to several contractors. Summary I have not received any report from the PWD since then, said Lokayukta N ...
 Indian Express2 weeks ago

A Patented Artist

(From Outlook 07 July 2014) The Outsiders Sanjay Mehrotra, 54, President, CEO, SanDisk Corporation BITS, Pilani Lola Nayar on Sanjay Mehrotra ...
 Outlook India1 month ago A Bridge Across Nations  Outlook India1 month ago

Role of SKAR in IFN signaling [Cell Biology]

Barbara Kroczynska a , b , Swarna Mehrotra a , b , Beata Majchrzak-Kita c , d , Ahmet Dirim Arslan a , b , Jessica K. Altman a , b , e , Brady L. Stein a , b , Brandon McMahon a , b , Piotr Kozlowski f , Philipp J. Kahle g , Elizabeth A.
 PNAS1 week ago

SanDisk's (SNDK) CEO Sanjay Mehrotra on Q2 2014 Results - Earnings Call Transcript

Operator Good day and welcome to the SanDisk Second Quarter 2014 Financial Results Conference Call. Today's conference is being recorded. At this time I would like to turn the conference over to Brendan Lahiff. Please go ahead, sir. ...
 Seeking Alpha1 week ago Johnson & Johnson's (JNJ) CEO Alex Gorsky on Q2 2014 Results - Earnings Call Transcript  Yahoo! Finance2 weeks ago Gilead Sciences' (GILD) CEO John Martin on Q2 2014 Results - Earnings Call Transcript  Yahoo! Finance6 days ago

Thrill of the drill

SINGAPORE - At his daughter's first birthday party, Mr Rohit Mehrotra was surprised by the sight of a once-pudgy friend who had shed kilos. Mr Mehrotra, who had been unsuccessfully trying to lose weight, asked for his friend's secret. The answer - ...
 Asiaone3 days ago
News India Times

Open-Air Defecation of 600 Million Indians Targeted by Inventor

Kartikay Mehrotra At least 54 million people in Asia can thank Bindeshwar Pathak when they defecate in private. If he has his way, about 600 million people in India who don't have that luxury will join them a decade from now. Pathak, 71, ...
 News India Times1 month ago Inventor Targets Open-Air Defecation of 600 Million Indians  BusinessWeek1 month ago
Stock Nod

IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p

/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for IMBRUVICA® (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at ...
 Financial Content2 days ago 7/28/14 - IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p  Pharmacy Choice1 day ago IMBRUVICA? (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p  Applied Clinical Trials1 day ago IMBRUVICA(r) (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic  Finwin2 days ago
[x]  
Scottrade

Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA for use in the Treatment of Two Forms of Blood Cancer

Release date- 25072014 - Beerse / Belgium - Janssen-Cilag International NV (Janssen) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the ...
 Pharmacy Choice1 day ago Janssen Submits EU Marketing Application for VELCADE® (bortezomib) in Mantle Cell Lymphoma  CNBC1 month ago VELCADE(R) Data at EHA 2014 Highlight Efficacy in -2-  Scottrade1 month ago VELCADE® Data at EHA 2014 Highlight Efficacy in Newly-Diagnosed Mantle Cell Lymphoma and Reinforce Its …  Yahoo! Finance1 month ago
[x]  

Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen's Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C

Study evaluated interferon-free combination in treatment-nave and prior null-responder patients with all stages of liver fibrosis, including cirrhosis CORK, Ireland--(BUSINESS WIRE)-- Results from the Phase 2 COSMOS ( C ombination O f S i M ...
 CNBC2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less